Literature DB >> 8602136

Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991.

C A Boyle1, M Yeargin-Allsopp, N S Doernberg, P Holmgreen, C C Murphy, D E Schendel.   

Abstract

PROBLEM/CONDITION: Serious developmental disabilities affect approximately 2% of school-age children and are lifelong conditions that incur substantial financial and societal costs. REPORTING PERIOD: January 1991-December 1991. DESCRIPTION OF SYSTEM: The Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP) monitors the prevalence of four serious developmental disabilities--mental retardation, cerebral palsy, vision impairment, and hearing impairment--among children 3-10 years of age in the five-county metropolitan-Atlanta area. Children who have at least one of the four developmental disabilities are ascertained through annual review of records at schools, hospitals, and other sources. RESULTS AND
INTERPRETATION: During 1991, rates for mental retardation varied by age, race, and sex; rates ranged from 5.2 per 1,000 children to 16.6 per 1,000 children. Regardless of the absolute rate of mental retardation in each of the age-, race-, and sex-specific categories, severe mental retardation (i.e., an intelligence quotient of <50) accounted for one third of all cases. The overall crude rate of cerebral palsy was 2.4 per 1,000 children; however, the rate was higher among black children (3.1 per 1,000 children) than among white children (2.0 per 1,000 children). The rate of moderate to severe hearing impairment was 1.1 per 1,000 children, and the rate of vision impairment was 0.8 per 1,000 children. Rates of hearing impairment were higher among black males than among children in the other race and sex groups, whereas rates for vision impairment varied only slightly between these groups. The rates of the developmental disabilities were not adjusted for possible confounding factors (e.g., maternal education, family income, and various medical conditions). Consequently, the variation in rates may reflect social or other characteristics unique to the study population. ACTIONS TAKEN: MADDSP data will be used to direct early childhood intervention efforts to reduce the prevalence of these four developmental disabilities. MADDSP data also are being used to measure progress toward the year 2000 national objectives for the prevention of serious mental retardation.

Entities:  

Mesh:

Year:  1996        PMID: 8602136

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  15 in total

1.  Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders.

Authors:  Rachel Nonkin Avchen; Lisa D Wiggins; Owen Devine; Kim Van Naarden Braun; Catherine Rice; Nancy C Hobson; Diana Schendel; Marshalyn Yeargin-Allsopp
Journal:  J Autism Dev Disord       Date:  2011-02

2.  A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation.

Authors:  Joseph J Higgins; Joanna Pucilowska; Roni Q Lombardi; John P Rooney
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

3.  Modifiable risk factors for low birth weight and their effect on cerebral palsy and mental retardation.

Authors:  Sarah A Collier; Carol J R Hogue
Journal:  Matern Child Health J       Date:  2007-01

4.  Mind the gap: gender differences in child special health care needs.

Authors:  Valerie Leiter; Patricia P Rieker
Journal:  Matern Child Health J       Date:  2012-07

5.  Sociodemographic risk factors for autism in a US metropolitan area.

Authors:  Tanya Karapurkar Bhasin; Diana Schendel
Journal:  J Autism Dev Disord       Date:  2007-04

6.  Cost of racial disparity in preterm birth: evidence from Michigan.

Authors:  Xiao Xu; Violanda Grigorescu; Kristine A Siefert; Jody R Lori; Scott B Ransom
Journal:  J Health Care Poor Underserved       Date:  2009-08

7.  Childhood vision impairment, hearing loss and co-occurring autism spectrum disorder.

Authors:  Vijaya Kancherla; Kim Van Naarden Braun; Marshalyn Yeargin-Allsopp
Journal:  Disabil Health J       Date:  2013-07-25       Impact factor: 2.554

Review 8.  Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  M R Delgado; D Hirtz; M Aisen; S Ashwal; D L Fehlings; J McLaughlin; L A Morrison; M W Shrader; A Tilton; J Vargus-Adams
Journal:  Neurology       Date:  2010-01-26       Impact factor: 9.910

9.  Chemicals in the environment and developmental toxicity to children: a public health and policy perspective.

Authors:  L R Goldman; S Koduru
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

10.  Profound hearing loss following surgery in pediatric patients with posterior fossa low-grade glioma.

Authors:  Yahya Ghazwani; Ibrahim Qaddoumi; Johnnie K Bass; Shengjie Wu; Jason Chiang; Frederick Boop; Amar Gajjar; Zsila Sadighi
Journal:  Neurooncol Pract       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.